1. Feng B, Tang X, Chen H, et al. Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients. Int Ophthalmol. 2018; 38:2117–2126.
Article
2. Sacchetti M, Mantelli F, Marenco M, et al. Diagnosis and management of iridocorneal endothelial syndrome. Biomed Res Int. 2015; 2015:763093.
Article
3. Lefebvre V, Sowka JW, Frauens BJ. The clinical spectrum between posterior polymorphous dystrophy and iridocorneal endothelial syndromes. Optometry. 2009; 80:431–436.
Article
4. Anderson NJ, Badawi DY, Grossniklaus HE, Stulting RD. Posterior polymorphous membranous dystrophy with overlapping features of iridocorneal endothelial syndrome. Arch Ophthalmol. 2001; 119:624–625.
Article
5. Kim NH, Kim MS. The clinical features and progression of the disease in posterior polymorphous corneal dystrophy (PPCD). J Korean Ophthalmol Soc. 2014; 55:368–373.
Article
6. Grayson M. The nature of hereditary deep polymorphous dystrophy of the cornea: its association with iris and anterior chamber dygenesis. Trans Am Ophthalmol Soc. 1974; 72:516–559.
7. Cibis GW, Tripathi RC. The differential diagnosis of Descemet's tears (Haab's striae) and posterior polymorpous dystrophy bands. A clinicopathologic study. Ophthalmology. 1982; 89:614–620.
8. Yanoff M. Iridocorneal endothelial syndrome: unification of a disease spectrum. Surv Ophthalmol. 1979; 24:1–2.
Article
9. Wilson MC, Shields MB. A comparison of the clinical variations of the iridocorneal endothelial syndrome. Arch Ophthalmol. 1989; 107:1465–1468.
Article
10. Laganowski HC, Kerr Muir MG, Hitchings RA. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992; 110:346–350.
Article
11. Chiou AG, Kaufman SC, Beuerman RW, et al. Confocal microscopy in the iridocorneal endothelial syndrome. Br J Ophthalmol. 1999; 83:697–702.
Article
12. Liskova P, Palos M, Hardcastle AJ, Vincent AL. Further genetic and clinical insights of posterior polymorphous corneal dystrophy 3. JAMA Ophthalmol. 2013; 131:1296–1303.
Article